Comparison of Triple Antibiotic Paste With Combination of Chitosan and Calcium Hydroxide as a Root Canal Disinfectant
Clinical and Radiographic Comparative Evaluation of Healing of Periapical Lesion Using Triple Antibiotic Paste With Combination of Chitosan and Calcium Hydroxide When Used as a Root Canal Disinfectant- An In Vivo Study
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Aim: To evaluate and compare the healing of periapical lesions using chitosan mixed with calcium hydroxide or Triple Antibiotic Paste at 3,6 and 12 months.
Methodology:
20 adult patients having periapical lesions in single rooted teeth were selected in this study after being assessed using the PAI index. Patients were randomly assigned to: Group - I (n=10) Chitosan with Ca (OH)2 and Group -II (n=10) Triple Antibiotic paste (TAP)
After access opening and cleaning and shaping were done in the first visit, the pertinent intracanal medicaments were placed depending on the patient group. After 4 weeks, on the second visit, the medicament was removed andobturation was done in the asymptomatic teeth. Both clinical and radiographic endodontic evaluation was done at 0, 3, 6 and 12months using the same parameters.
Radiographic evaluation was done using the PAI Index and was compared at 0, 3, 6, and 12 months after treatment, Z Test.
Studietype
Inschrijving (Verwacht)
Fase
- Fase 2
- Fase 3
Contacten en locaties
Studiecontact
- Naam: Soumya S Shetty, MDS
- Telefoonnummer: 8888200888
- E-mail: drsoumyasshetty@gmail.com
Studie Contact Back-up
- Naam: anita B Tandale, MDS
- Telefoonnummer: 9850537432
- E-mail: anita.tandale@gmail.com
Studie Locaties
-
-
Maharashtra
-
Pune, Maharashtra, Indië, 411 018
- Werving
- Dr DY Patil Dental College And Hospital (DPU)
-
Contact:
- Soumya S Shetty, MDS
- Telefoonnummer: 8888200888
- E-mail: drsoumyasshetty@gmail.com
-
Contact:
- anita B Tandale, MDS
- Telefoonnummer: 9850537432
- E-mail: anita.tandale@gmail.com
-
Hoofdonderzoeker:
- soumya S shetty, MDS
-
Onderonderzoeker:
- anita B tandale, MDS
-
Onderonderzoeker:
- piyush D oswal, MDS
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Patients aged between 18 and 40 years Periapical lesion (not more than 5mm) radiographically.on single rooted teeth
- Roots with closed apex.
- Systemically healthy patients.
Exclusion Criteria:All patients who respond positive to allergic patch test [triple antibiotic paste] and drugs.
- Teeth with previous endodontic therapy performed.
- Patients with a history of any systemic diseases.
- Pregnant and lactating women.
- Tooth associated with vertical root fracture and coronal perforation.
- Tooth affected with calcific degeneration.
- Presence of external or internal root resorption.
- Blunderbuss apex.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Chitosan calcium hyroxide paste
after the access preparation and cleaning and shaping, chitosan calcium hydroxide paste will be placed in the canal and kept for 4 weeks.
|
after the access preparation and cleaning and shaping was done in 1st appointment using k files,"Mani" and protapers,"Dentsply" then in, chitosan calcium hydroxide paste," or ciprofloxacin metronidazole minocycline paste placed in the canal and kept for 4 weeks.
Andere namen:
|
|
Actieve vergelijker: triple antibiotic paste
after the access preparation and cleaning and shaping, ciprofloxacin metronidazole minocycline paste will be :placed in the canal and kept for 4 weeks.
|
after the access preparation and cleaning and shaping was done in 1st appointment using k files,"Mani" and protapers,"Dentsply" then in, chitosan calcium hydroxide paste," or ciprofloxacin metronidazole minocycline paste placed in the canal and kept for 4 weeks.
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
healing of periapical lesion
Tijdsspanne: change in PAI index from baseline to 3 months, baseline to 6 months and baseline to 12 months
|
the periapical status will be assessed by using the periapical index [PAI] using radiographs and scoring was done according to following scoring index as
|
change in PAI index from baseline to 3 months, baseline to 6 months and baseline to 12 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
patient pain perception
Tijdsspanne: 3months, 6months and 12 months
|
pain will be assessed using visual analogue (VAS )scale along with any swelling following scale of -10 with 0 score depicts no pain and score 10 depicts severe pain
|
3months, 6months and 12 months
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Piyush D Oswal, MDS, Dr. D Y Patil Dental College, Pimpri, Pune
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- DYPV/EC/55/16
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .